more bad news from macbank, page-6

Hi Mita

Axiron supplies patches in the testosterone gel market. Last year in the US was $2 Billion in sales. This is forecast to double by 2017.

Have a read of this article:
http://www.nytimes.com/2013/10/16/us/a-push-to-sell-testosterone-gels-troubles-doctors.html?_r=0

I wonder how Macquarie Bank research are interpreting the data they are getting. Doesn't seem they have a good insight into the actual target market segment.

Note, haven't read any reports, however from the snippets in the press and on hotcopper, not sure of the quality.

Best of Luck
Lost